Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2022 Results - Earnings Call Transcript
- Calyxt, Inc. (NASDAQ:CLXT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
- 08/07/2022
|
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference
- ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A.
- 07/28/2022
|
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
- ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:30 p.m.
- 07/21/2022
|
Calyxt, Inc. (CLXT) CEO Michael Carr on Q1 2022 Results - Earnings Call Transcript
- Calyxt, Inc. (NASDAQ:CLXT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
- 05/08/2022
|
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
- ROSEVILLE, Minn. , April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m.
- 04/21/2022
|
Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down
- Calyxt is now on to its third business plan, pivoting from gene-edited seed traits to synthetic biology. The company is looking to produce molecules of interest to pharmaceutical, nutraceutical, and cosmeceutical companies through sustainable plant-based technology.
- 04/01/2022
|
Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q4 2021 Results - Earnings Call Transcript
- Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q4 2021 Results - Earnings Call Transcript
- 03/03/2022
|
Calyxt (CLXT) Reports Q4 Loss, Misses Revenue Estimates
- Calyxt (CLXT) delivered earnings and revenue surprises of 17.39% and 42.28%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/03/2022
|
Calyxt to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time
- ROSEVILLE, Minn., Feb. 24, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will hold a conference call on Thursday, March 3, 2022, at 4:30 p.m.
- 02/24/2022
|
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
- Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration.
- 12/31/2021
|
Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum
- ROSEVILLE, Minn., Nov. 23, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that management will present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum.
- 11/23/2021
|
Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q3 2021 Results - Earnings Call Transcript
- Calyxt, Inc.'s (CLXT) CEO Michael Carr on Q3 2021 Results - Earnings Call Transcript
- 11/07/2021
|
5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175%
- Some of the best penny stocks 2021 has offered were some of… The post 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 11/02/2021
|
Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know
- Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/28/2021
|
Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers
- ROSEVILLE, Minn., Oct. 5, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Company on engineering synthetic biology solutions for a diversified base of customers across an expanded group of end markets including the nutraceutical, cosmeceutical, pharmaceutical, advanced materials, and chemical industries.
- 10/05/2021
|
Calyxt Seeks To Develop Palm Oil Alternative
- Calyxt Inc (NASDAQ: CLXT) has entered into a research collaboration with a food ingredient manufacturer based in Asia to develop an improved soybean to produce oil as a commercial alternative to palm oil. As part of the research collaboration, Calyxt will receive cash payments in each of the two years of its term.
- 09/28/2021
|
Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative
- ROSEVILLE, Minn., Sept. 28, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based technology platform company, today announced it entered into a research collaboration with a leading global food ingredient manufacturer based in Asia to develop an improved soybean capable of producing an oil as a commercial alternative to palm oil.
- 09/28/2021
|
Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2021 Results - Earnings Call Transcript
- Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2021 Results - Earnings Call Transcript
- 08/08/2021
|
Calyxt: Q2 Earnings Insights
- Shares of Calyxt (NASDAQ:CLXT) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 36.36% over the past year to ($0.21), which missed the estimate of ($0.19).
- 08/05/2021
|
Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021
- ROSEVILLE, Minn., Aug. 4, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based biotechnology platform company, today announced that management will present at the Canaccord Genuity 41st Annual Growth Conference at 11:00 a.m.
- 08/04/2021
|
Calyxt (CLXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2021
|
Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time
- ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m.
- 07/19/2021
|
Calyxt Appoints Michael A. Carr As CEO
- Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.
- 07/16/2021
|
Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation
- Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics ROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CLXT), today announced further expansion of its hemp breeding platform with the addition of triploid breeding technology to create seedless hemp. Bringing this technology to hemp cultivation comes on the heels of the company announcing the successful transformation of the hemp genome.
- 07/08/2021
|
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century
- Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy. The post The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century appeared first on InvestorPlace.
- 07/01/2021
|
Calyxt: Proprietary TALEN Plant-Technology Offers Multi-Industry Growth
- Calyxt is a plant-technology company that develops plant-based innovations and solutions aiming to disrupt a broad group of industries. Calyxt is a leading gene-editor with exclusive access to the parent company's proprietary TALEN technology for use in plants which resulted in the first successfully US-commercialized gene-edited food product.
- 06/23/2021
|
Calyxt, Inc. (CLXT) Q1 2021 Results - Earnings Call Transcript
- Calyxt, Inc. (CLXT) Q1 2021 Results - Earnings Call Transcript
- 05/09/2021
|
Calyxt Announces Next Generation Premium Soybean Product Line Performance Best-In-Class for High Oleic, Ultra-Low Linolenic Profile
- Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the Market R&D Advancement with Complex Plant Biological Pathways Enables Calyxt to Deliver Next Generation Plant-Based Solutions in Rapid Time Frame ROSEVILLE, MN / ACCESSWIRE / May 4, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, announced today that its next generation premium high oleic low linolenic (HOLL) soybean oil trait has exceeded industry performance targets expected in the premium oil segment. This marks a step-improvement on Calyxt's first gene-edited product that was commercialized in the U.S. by delivering superior functional performance plus a -superior functional performance and fatty acid profile superior to other premium oils.
- 05/04/2021
|
Calyxt Successfully Transforms Hemp Genome
- New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending Transformation Process is Calyxt's First Announced Innovation in a Broad Hemp Improvement Pipeline ROSEVILLE, MN / ACCESSWIRE / April 29, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, announced today that it has successfully transformed hemp genome, enabling a step-change in innovation approaches in the species.
- 04/29/2021
|
Calyxt to Present at Upcoming Investor and Industry Conferences
- ROSEVILLE, MN / ACCESSWIRE / April 20, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May 2021: 2021 American Oil Chemists Society (AOCS) Annual Meeting & Expo Date: May 4, 2021 Time: 4:00 p.m.
- 04/20/2021
|
Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time
- Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, Ma y 6 , 202 1 at 4 :30 p .m. Eastern Time ROSEVILLE, MN / ACCESSWIRE / April 15, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, will hold a conference call on Thursday, May 6, 2021 at 4:30 p.m.
- 04/15/2021
|
Calyxt Using A More Conventional Model To Pursue Significant New Agri-Bio Market Opportunities
- Calyxt has changed its operating strategy to a more conventional agri-bio seed/trait model similar to those pursued by established agri-bio names like Bayer and Corteva. Calyxt is targeting new high-risk/high-reward market opportunities including winter oats, hemp, and soybeans with saturated fat content that could be a substitute for palm oil.
- 03/24/2021
|
Calyxt, Inc. (CLXT) Q4 2020 Results - Earnings Call Transcript
- Calyxt, Inc. (CLXT) Q4 2020 Results - Earnings Call Transcript
- 03/04/2021
|
Calyxt (CLXT) Reports Q4 Loss, Tops Revenue Estimates
- Calyxt (CLXT) delivered earnings and revenue surprises of -32.00% and 77.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 03/04/2021
|
Recap: Calyxt Q4 Earnings
- -Shares of Calyxt (NASDAQ:CLXT) were flat after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 10.81% year over year to ($0.33), which missed the estimate of ($0.22).
- 03/04/2021
|
Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results
- Continued to Progress Development of Winter Oats and Hemp, Both Targeted at Large Addressable Markets Secured Commitment from ADM to Purchase Remaining 2019 Grain Inventory and All 2020 Grain Production - Have Completed Sale of 40 Percent of 2020 Grain Crop Executed Commercial Agreement with S&W Seed Company on IQ™ Alfalfa Product, Marking Calyxt's First Trait License Agreement Management to Host Conference Call Today at 4:30 p.m. ET ROSEVILLE, MN / ACCESSWIRE / March 4, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, has reported its financial results for the fourth quarter and full year ended December 31, 2020.
- 03/04/2021
|
Should You Buy Calyxt (CLXT) Ahead of Earnings?
- Calyxt (CLXT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 03/03/2021
|
Calyxt to Present at Upcoming March Investor Conferences
- ROSEVILLE, MN / ACCESSWIRE / March 3, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor conferences during the month of March 2021: Bank of America Securities 2021 Global Agriculture & Materials Virtual Conference Date: Wednesday, March 3, 2021 Time: 11:00 a.m.
- 03/03/2021
|
Calyxt Completes New Scientific Advisory Board with Key Appointments
- World-Renowned Plant-Biochemistry Experts Named to Calyxt's Scientific Advisory Board Chaired by Company Co-Founder Dan Voytas, Ph.D. New Strategic Initiative to Identify High Value Plant-Derived Products Utilizing Calyxt's Proprietary Innovation Platform ROSEVILLE, MN / ACCESSWIRE / March 2, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, has completed key appointments to its previously announced Scientific Advisory Board (SAB) to identify high value plant-derived product targets that will be produced utilizing Calyxt's proprietary innovation platform.
- 03/02/2021
|
Calyxt powers advances in plant sciences, crop traits and building robust portfolio of products
- Calyxt sells a premium soybean cooking oil Calyno TALEN gene-editing technology is a game-changer Strong management team with proven track record What Calyxt does: Calyxt Inc (NASDAQ:CLXT) is a plant-based technology company, which is developing healthier specialty food ingredients and food crops using gene-editing technology. Founded in 2010, the Roseville, Minnesota-based company is doing what farmers and botanists have been doing for hundreds of years: choosing the best crops and breeding them to make higher-yielding plants.
- 02/16/2021
|
Calyxt shares climb after Canaccord analyst doubles price target to $16, repeats 'Buy' rating
- Calyxt Inc (NASDAQ:CLXT) shares jumped Tuesday after an analyst at Canaccord Genuity Capital markets doubled the firm's price target for the company from $8 to $16 and reiterated a "Buy" rating in a note to clients published late Monday. The firm's increasingly bullish stance follows Calyxt's decision in December to sell all 2020 grain production of its high oleic soybean to agriculture giant Archer-Daniels-Midland Company (NYSE:ADM).
- 02/16/2021
|
Are You Looking for a Top Momentum Pick? Why Calyxt (CLXT) is a Great Choice
- Does Calyxt (CLXT) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 02/12/2021
|
Moving Average Crossover Alert: Calyxt (CLXT)
- Calyxt (CLXT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- 02/02/2021
|
5 High-Flying Stocks Set to Move Higher
- These 5 stocks have good reason for further upside.
- 01/29/2021
|
Here's Why Calyxt (CLXT) is a Great Momentum Stock to Buy
- Does Calyxt (CLXT) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 01/25/2021
|
7 CRISPR Stocks for the Future of Medicine
- Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century. The post 7 CRISPR Stocks for the Future of Medicine appeared first on InvestorPlace.
- 01/15/2021
|
Calyxt Announces Sale of Entire 2020 Grain Production to ADM
- ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soybean to ADM (NYSE: ADM), a global leader in human and animal nutrition and the world's premier agricultural origination and processing company headquartered in Chicago. The transaction is a key step in Calyxt's 2020 transition to an advanced go-to-market strategy focused on providing plant-based innovation
- 12/14/2020
|
Calyxt To Exit Farming Operations And Focus On Seed Science
- Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies.
- 12/10/2020
|
Calyxt Announces Collaboration with NRGene® to Advance its Product Pipeline
- ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene's cloud-based genomics platform to support key Calyxt's research projects. The genomics solutions are expected to allow for more comprehensive evaluations to accelerate trait discovery and breeding across multiple crops. Calyxt is leveraging its proprietary breeding techniques and TALEN® technology to optimiz
- 11/11/2020
|
Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2020 Results - Earnings Call Transcript
- Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2020 Results - Earnings Call Transcript
- 11/08/2020
|
Calyxt Announces Commercial Agreement with S&W Seed Company to Deliver Improved Quality Alfalfa
- ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq: SANW), a global agricultural company headquartered in Longmont, Colorado for the exclusive license of an improved quality alfalfa seed in the U.S. and other select geographies. This marks the company's first commercial trait license agreement and, based on U.S. sales projections, could potentially generate mor
- 10/29/2020
|
Calyxt to Host Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern Time
- ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The Virtual Analyst Day will be broadcasted via webcast, and include a review of the company's research and development pipeline and a business update from management, followed by a Q&A session with the sell-side analyst community. Agenda: Date: Tuesday, November 17, 2020 Presentation Time: 4:00 p.m. Easter
- 10/27/2020
|
Financial Comparison: China Agri-Business (OTCMKTS:CHBU) & Calyxt (OTCMKTS:CLXT)
- China Agri-Business (OTCMKTS:CHBU) and Calyxt (NASDAQ:CLXT) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk. Insider and Institutional Ownership 24.1% of Calyxt shares are held by institutional investors. 2.3% of Calyxt […]
- 10/17/2020
|
Bankruptcy Update: Ruby Tuesday Files Chapter 11 While Progress Slows For JCPenney
- The list of bankruptcies this year continues to grow.
Casual food chain Ruby Tuesday filed for Chapter 11 protection on Wednesday. The Tennessee-based company ...
- 10/11/2020
|
Processed Potatoes Market to Reach USD 37.74 bn by 2024, Burts Potato Chips Ltd. and Calbee Inc. Emerge as Key Contributors to Growth | Technavio
- The Global Processed Potatoes Market will grow by USD 37.74 bn during 2020-2024
- 10/06/2020
|
Centric Brands Announces Confirmation of Plan of Reorganization
- Centric Brands Inc. (OTCBB: CTRCQ) (the “Company”), a leading lifestyle brands collective, announced today that the United States Bankruptcy Court for
- 09/18/2020
|
Century 21, J.C. Penney And J. Crew Are Just 3 Retailers On A Long List Of 2020 Bankruptcies
- Century 21 Department Stores LLC grabbed headlines last week when it confirmed plans to close all 13 of its stores and liquidate assets as part of a chapter 11 process.
In doing...
- 09/13/2020
|
Calyxt -Shareholder Analyst Call
- The following slide deck was published by Calyxt, Inc. in conjunction with this event..
- 09/03/2020
|
Kansas Wheat offers progress report
- Aaron Harries, vice president of research and operations for Kansas Wheat provided an annual update on activities and research conducted by the Kansas Association of Wheat Growers and Kansas Wheat
- 08/17/2020
|
Calyxt's (NASDAQ:CLXT) Stock Price Has Reduced53% In The Past Three Years
- While it may not be enough for some shareholders, we think it is good to see the Calyxt, Inc. (NASDAQ:CLXT) share...
- 08/10/2020
|
Does Calyxt (NASDAQ:CLXT) Have A Healthy Balance Sheet?
- Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- 08/10/2020
|
Calyxt Reports Second Quarter 2020 Financial Results
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the second quarter ended June 30, 2020.
- 08/05/2020
|
LD Micro - Announces Preliminary List of Presenters for the LD-500
- LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
- 08/05/2020
|
Calyxt to Present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place on August 11 to 13, 2020.
- 08/03/2020
|
Calyxt to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020 at 8:00 a.m. Eastern Time
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, August 6, 2020 at 8:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2020. A press release detailing these results will be issued prior to the call.
- 07/20/2020
|
Calyxt Announces Board Changes
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appointment coincides with Dr. André Choulika's decision to wholly focus his energy on Cellectis’ clinical development activities, and thus, retiring as Chairman of Calyxt’s Board. Additionally, Calyxt’s Board of Directors appointed Laurent Arthaud (Cellectis Board member) as Director. These changes are effective immediately.
- 07/06/2020
|
Calyxt Announces Board Changes
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. Thi
- 07/06/2020
|
FAST: Future Proofing The Retail Food Industry
- Understandably, the retail food industry has been consumed with responding to current events. With a global pandemic rocking the market, we have seen an unprecedented impact on the retail industry in general and the food industry in particular.
- 07/01/2020
|
How Centric Plans to Transform the Face of Cryptocurrency | Coinspeaker
- By utilizing a two-token system, Centric hopes to provide the market with a stable form of currency that could actually replace fiat currencies.
- 06/25/2020
|
Stephen Takacsy's Top Picks: June 16, 2020 - BNN Bloomberg
- Top picks from Stephen Takacsy, president, CEO and chief investment officer at Lester Asset Management.
- 06/16/2020
|
Specialty Food Ingredients Market 2020 Global Top Countries Industry Size, Share, Business Growth, Revenue, Trends, Global Market Demand Penetration and Forecast to 2024
- Jun 11, 2020 (The Expresswire) --
“Specialty Food Ingredients Market" 2020-2024 Report Provides Market Share, CAGR, Production, Consumption, Revenue, Gross...
- 06/11/2020
|
5 Crypto Executive Predictions On Where The Economy Is Headed
- In 2020, the world has embraced uncertainty as the new norm. Market volatility has reached record levels, leading to a surge in trading volume and opportunities for value...
- 06/08/2020
|
Is Calyxt, Inc. (CLXT) A Good Stock To Buy?
- In this article we will take a look at whether hedge funds think Calyxt, Inc. (NASDAQ:CLXT) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from […]
- 06/04/2020
|
Calyxt’s High Oleic Low Linolenic Soybean Oil Deemed Non-Regulated by USDA
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that its high oleic low linolenic (HOLL) soybean has been deemed a non-regulated article under the "Am I Regulated?" process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service (APHIS), an agency of the United States Department of Agriculture (USDA).
- 06/03/2020
|
Centric Software's Easy Digital Collaboration With Personal PLM
- Centric 8 PLM v7.1introduces an individualized PLM experience,enhanced 3D innovationsand more.
- 05/28/2020
|
Specialty Food Ingredients Market 2020 Global Covid-19 Impact Analysis, Trends, Opportunities and Forecast to 2026
- May 25, 2020 (Heraldkeepers) --
Specialty Food Ingredients Market 2020 Report OverviewThis report has been prepared with a comprehensive analysis of the...
- 05/25/2020
|
Blackstone to Keep a Centric Brands Stake Under Chapter 11 Restructuring | MarketScreener
|
Centric Brands Files for Bankruptcy
- The umbrella group holds licenses for over 100 brands.
- 05/18/2020
|
Calyxt (CLXT) Moves to Strong Buy: Rationale Behind the Upgrade
- Calyxt (CLXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
- 05/18/2020
|
US$6.33: That's What Analysts Think Calyxt, Inc. (NASDAQ:CLXT) Is Worth After Its Latest Results
- Calyxt, Inc. (NASDAQ:CLXT) just released its latest quarterly report and things are not looking great. Earnings missed...
- 05/09/2020
|
Calyxt's (CLXT) CEO Jim Blome on Q1 2020 Results - Earnings Call Transcript
- Calyxt, Inc. (NASDAQ:CLXT) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET Company Participants Chris Tyson – Managing Director-MZ North America Jim Blo
- 05/08/2020
|
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
- Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Computer Programs and Systems Inc : Cantor Fitzgerald raises to overweight from neutral
* Epam Systems Inc : Citigroup raises price target to $265 from $245
* PayPal Holdings Inc : Citigroup raises price target to $145 from $131
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical
order.
* Aaron's Inc : Keybanc cuts target price to $55 from $66
* Aaron's Inc : Raymond James cuts target price to $50 from $60
* Aaron's Inc : Stephens raises target price to $45 from $26
* Abeona Therapeutics Inc : RBC cuts target price to $7 from $11
* Acceleron pharma Inc : Credit Suisse raises target price to $123 from $99
* ACI Worldwide Inc : Canaccord Genuity cuts target price to $35 from $44
* Acushnet Holdings Corp : Jefferies raises target price to $25 from $24
* Acushnet Holdings Corp : JP Morgan raises target price to $30 from $27
* Adtran Inc : Cowen and Company raises price target to $13 from $9
* Aeglea Bio Therapeutics Inc : Needham cuts price target to $11 from $14
* Aerie Pharmaceuticals Inc : Citigroup cuts price target to $38 from $39
* Agco Corp : Citigroup cuts price target to $55 from $57
* AIG : KBW raises target price to $36 from $35
* Alaska Air Group Inc : Credit Suisse cuts target price to $51 from $82
* Allison Transmission Holdings Inc : Citigroup raises price target to $39 from $38
* Allscripts Healthcare Solutions : Cantor Fitzgerald cuts PT to $6 from $8
* Alteryx Inc : Guggenheim cuts target price to $130 from $160
* American Airlines : Credit Suisse cuts target price to $4 from $26
* Ameriprise Financial Inc : Credit Suisse raises target price to $165 from $153
* Ameriprise Financial Inc : Piper Sandler raises target price to $150 from $130
* Amerisourcebergen Corp : Baird raises target price to $115 from $109
* Amerisourcebergen Corp : Mizuho raises target price to $90 from $85
* Amtech Systems Inc : Cowen and Company raises target price to $7.50 from $7
* Angi Homeservices Inc : Needham raises target price to $11 from $8
* Ani Pharmaceuticals Inc : Guggenheim cuts target price to $48 from $58
* Ansys Inc : RBC raises target price to $260 from $230
* Anthem Inc : Bernstein raises target price to $357 from $342
* Appian Corp : Cowen and Company raises price target to $44 from $39
* Applied Optoelectronics Inc : D.A. Davidson raises target price to $12 from $10
* Applied Optoelectronics Inc : Piper Sandler raises target price to $10 from $7.50
* Aptiv Plc : Citigroup raises price target to $84 from $67
* ArcelorMittal SA : Keybanc raises target price to $15 from $13
* Arcturus Therapeutics Holdings Inc : Baird raises target price to $44 from $26
* Arcturus Therapeutics Holdings Inc : Guggenheim raises target price to $51 from $41
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Athersys Inc : Needham cuts price target to $5 from $6
* Atlas Air Worldwide Holdings Inc : Cowen and Company raises PT to $44 from $40
* Avalara Inc : Canaccord Genuity raises target price to $115 from $105
* Avalara Inc : JP Morgan raises target price to $120 from $104
* Avalara Inc : Mizuho raises price target to $120 from $85
* Avalara Inc : Piper Sandler raises target price to $113 from $90
* Avalonbay Communities Inc : Stifel raises target price to $176 from $171
* Avrobio Inc : Guggenheim raises target price to $50 from $49
* Axalta Coating Systems Ltd : RBC raises target price to $21 from $20
* Bausch Health Companies Inc : Piper Sandler cuts target price to $32 from $34
* Beacon Roofing Supply Inc : SunTrust Robinson raises target price to $26 from $24
* Beacon Roofing Supply Inc : Wedbush raises target price to $23 from $16
* Becton Dickinson and Co : Citigroup raises price target to $260 from $234
* Becton Dickinson and Co : Evercore ISI raises target price to $270 from $255
* Beyond Meat Inc : Berenberg raises price target to $125 from $115
* Bill.Com Holdings Inc : Canaccord Genuity raises target price to $65 from $50
* Bill.Com Holdings Inc : Jefferies raises target price to $70 from $45
* Bill.Com Holdings Inc : Keybanc raises target price to $76 from $60
* Bill.Com Holdings Inc : Needham raises target price to $90 from $55
* Biomarin Pharmaceutical Inc : Canaccord Genuity raises PT to $119 from $108
* BJ's Restaurants Inc : Wedbush cuts target price to $32 from $39
* Booking Holdings Inc : Credit Suisse raises target price to $1,810 from $1,790
* Booking Holdings Inc : Jefferies cuts target price to $1300 from $1350
* Booking Holdings Inc : Mizuho cuts price target to $1700 from $1720
* Booking Holdings Inc : RBC raises target price to $1,550 from $1,535
* Booking Holdings Inc : RBC raises target price to $1550 from $1535
* BorgWarner Inc : Citigroup raises price target to $30 from $23
* BorgWarner Inc : Credit Suisse raises target price to $33 from $31
* Bottomline Technologies (De) Inc : Citigroup raises price target to $46 from $43
* Bright Horizons Family Solutions Inc : Citigroup raises PT to $122 from $80
* Brightsphere Investment Group Inc : Evercore ISI raises target to $9 from $6
* Brightsphere Investment Group Inc : KBW raises target price to $9.50 from $7.25
* Brightview Holdings Inc : Credit Suisse cuts target price to $14 from $18
* Brightview Holdings Inc : Jefferies raises target price to $14 from $12
* Cabot Microelectronics Corp : Citigroup cuts price target to $140 from $175
* Cactus Inc : zephirin Group raises price objective to $12 from $8
* Calithera Biosciences Inc : Jefferies raises target price to $9 from $6
* Calyxt Inc : BMO cuts price target to $7 from $13
* Calyxt Inc : BMO cuts to market perform from outperform
* Camping World Holdings Inc : Credit Suisse raises target price to $12 from $11
* Camping World Holdings Inc : JP Morgan raises price target to $11 from $10
* Capstar Financial Holdings Inc : KBW raises target price to $11 from $10.50
* Cargurus Inc : BTIG raises target price to $26 from $23
* Carrols Restaurant Group Inc : Craig-Hallum raises to buy from hold; raises target price to $5 from $3.75
* Castlight Health Inc : Cantor Fitzgerald cuts target price to $1 from $2
* Catasys Inc : Canaccord Genuity raises target price to $36 from $35
* CBRE Group Inc : Evercore ISI cuts target price to $48 from $50
* CBRE Group Inc : KBW cuts target price to $51 from $52
* Centerpoint Energy Inc : Guggenheim raises target price to $26 from $25
* Centerpoint Energy Inc : Keybanc raises target price to $16 from $12
* Centurylink Inc : RBC cuts target price to $10 from $14
* CF Industries Holdings Inc : Citigroup cuts price target to $29 from $31
* CF Industries Holdings Inc : Scotiabank raises target price to $32 from $31
* ChannelAdvisor Corp : Needham raises price target to $14 from $11
* Charles River Laboratories International : Credit Suisse cuts PT to $159 from $162
* Charles River Laboratories International : Evercore ISI ups PT to $176 from $154
* Charles River Laboratories International : Jefferies raises PT to $161 from $139
* Charles River Laboratories International Inc : Citigroup raises price target to $190 from $165
* Chart Industries Inc : zephirin Group raises price objective to $25 from $17
* Charter Communications Inc : Benchmark raises price target to $600 from $523
* Chemours Co : Citigroup raises price target to $13 from $8
* Cimarex Energy Co : MKM Partners raises target price to $34 from $31
* City Holding Co : Stephens cuts target price to $63 from $64.
- 05/08/2020
|
Calyxt: Q1 Earnings Insights
- Shares of Calyxt (NASDAQ:CLXT) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were down 47.83% year over year to ($0.34), which missed the estimate of ($0.32).Revenue of $2,377,000 up by 1414.01% year over year, which missed the estimate of $4,060,000.Outlook Earnings guidance hasn't been issued by the company for now.Calyxt hasn't issued any revenue guidance for the time being.How To Listen To The Conference Call Date: May 07, 2020View more earnings on CLXTTime: 09:05 AM ETWebcast URL: https://viavid.webcasts.com/starthere.jsp?ei=1299871&tp;_key=0b5db2d0d1Technicals 52-week high: $16.48Company's 52-week low was at $2.40Price action over last quarter: Up 5.02%Company Overview Calyxt Inc is an agricultural biotechnology company. It mainly engages in the development of food and agricultural business. The company develops and creates specialty food ingredients, such as oils and high fiber wheat, and food crops with desirable traits such as herbicide tolerance. It develops products such as reduced trans-fat soya oil, potato, gluten reduced wheat, and lower saturated fat canola oil. It generates all of its revenue from R&D; contracts related to plant gene editing.See more from Benzinga * Recap: Albireo Pharma Q1 Earnings * Recap: International Seaways Q1 Earnings * Recap: Oaktree Specialty Lending Q2 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 05/07/2020
|
Calyxt Reports First Quarter 2020 Financial Results
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the first quarter ended March 31, 2020.
- 05/07/2020
|
Cellectis : publie ses résultats financiers du premier trimestre 2020 | Zone bourse
|
Bank of New York Mellon Corp Sells 7,684 Shares of Calyxt Inc (NASDAQ:CLXT)
- Bank of New York Mellon Corp lessened its holdings in shares of Calyxt Inc (NASDAQ:CLXT) by 25.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,534 shares of the company’s stock after selling 7,684 shares during the quarter. Bank of […]
- 05/02/2020
|
Calyxt Launches Consumer E-Commerce Channel for Calyno® Premium Cooking Oil
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched a retail offering of Calyno® cooking oil, the company’s first commercial product, a premium, high-performing oil, through the company’s newly launched e-commerce website calyno.com.
- 04/30/2020
|
Calyxt (NASDAQ:CLXT) Raised to "Buy" at Zacks Investment Research
- Zacks Investment Research upgraded shares of Calyxt (NASDAQ:CLXT) from a hold rating to a buy rating in a research note released on Monday morning, Zacks.com reports. Zacks Investment Research currently has $4.75 price target on the stock. According to Zacks, “Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and […]
- 04/30/2020
|
Calyxt (CLXT) to Release Quarterly Earnings on Thursday
- Calyxt (NASDAQ:CLXT) is scheduled to announce its earnings results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter. Calyxt has set its FY 2020 Pre-Market guidance at EPS.Parties interested in participating in the company’s conference call can do so using this link. […]
- 04/30/2020
|
We’re Keeping An Eye On Calyxt’s (NASDAQ:CLXT) Cash Burn Rate
- We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- 04/29/2020
|
-$0.33 Earnings Per Share Expected for Calyxt Inc (NASDAQ:CLXT) This Quarter
- Analysts forecast that Calyxt Inc (NASDAQ:CLXT) will report ($0.33) earnings per share for the current quarter, Zacks reports. Zero analysts have made estimates for Calyxt’s earnings. Calyxt reported earnings per share of ($0.23) during the same quarter last year, which suggests a negative year-over-year growth rate of 43.5%. The firm is scheduled to report its […]
- 04/19/2020
|
Calyxt to Host First Quarter 2020 Financial Results Conference Call on Thursday, May 7, 2020 at 8:30 a.m. Eastern Time
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, May 7, 2020 at 8:30 a.m. Eastern time to discu
- 04/14/2020
|
Calyxt Licenses New Enabling Technology from University of Minnesota for Greater Efficiency in Gene Edited Plants
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential to reduce the time needed to edit plants from approximately one year to several months.
- 04/07/2020
|
The Promise And Fear Of Gene Editing
- It’s easy to talk about gene editing and genetic modification in terms that sound like science fiction. But as much as that may drive clicks for media sensationalists, it does more harm than good for those who really want to understand where the science came from and where it’s going.
- 03/30/2020
|
Analysts Expect Calyxt Inc (NASDAQ:CLXT) to Post -$0.33 Earnings Per Share
- Wall Street brokerages predict that Calyxt Inc (NASDAQ:CLXT) will announce ($0.33) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Calyxt’s earnings. Calyxt posted earnings per share of ($0.23) during the same quarter last year, which suggests a negative year-over-year growth rate of 43.5%. The […]
- 03/27/2020
|
Calyxt Launches New Website Showcasing the Power and Possibilities of Plants
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched its new website to showcase how Calyxt is harnessing the ‘Power and Possibilities of Plants’.
- 03/24/2020
|
Calyxt Inc (NASDAQ:CLXT) Stake Raised by State Street Corp
- State Street Corp increased its holdings in Calyxt Inc (NASDAQ:CLXT) by 9.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,450 shares of the company’s stock after acquiring an additional 13,495 shares during the period. State Street Corp owned […]
- 03/24/2020
|
Jefferies downgrades 10 'lower conviction' Chemicals stocks to Hold ASH;AXTA;CC;CLXT;DCI;GCP;GPRE;GRA;VNTR;VVV
- Jefferies downgrades 10 'lower conviction' Chemicals stocks to Hold Jefferies ASH AXTA CC CLXT DCI GCP GPRE GRA VNTR VVV
- 03/23/2020
|
Calyxt (NASDAQ:CLXT) Downgraded by Zacks Investment Research
- Zacks Investment Research cut shares of Calyxt (NASDAQ:CLXT) from a hold rating to a sell rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat […]
- 03/16/2020
|
Calyxt Inc (NASDAQ:CLXT) Shares Acquired by KBC Group NV
- KBC Group NV increased its holdings in Calyxt Inc (NASDAQ:CLXT) by 3,558.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,000 shares of the company’s stock after acquiring an additional 14,590 shares during the quarter. KBC Group NV’s holdings in Calyxt were worth […]
- 03/12/2020
|
Calyxt (NASDAQ:CLXT) Earns Buy Rating from National Securities
- National Securities restated their buy rating on shares of Calyxt (NASDAQ:CLXT) in a research note published on Friday, AnalystRatings.com reports. The brokerage currently has a $16.00 price target on the stock. Several other research analysts have also recently issued reports on CLXT. Goldman Sachs Group cut Calyxt from a buy rating to a neutral rating […]
- 03/09/2020
|
Calyxt (NASDAQ:CLXT) Downgraded to Equal Weight at Wells Fargo & Co
- Wells Fargo & Co downgraded shares of Calyxt (NASDAQ:CLXT) from an overweight rating to an equal weight rating in a research note published on Friday, BenzingaRatingsTable reports. The brokerage currently has $6.00 target price on the stock, down from their prior target price of $15.00. A number of other equities research analysts have also recently […]
- 03/09/2020
|
Fmr LLC Has $27.21 Million Stock Holdings in Calyxt Inc (NASDAQ:CLXT)
- Fmr LLC trimmed its stake in shares of Calyxt Inc (NASDAQ:CLXT) by 19.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,881,700 shares of the company’s stock after selling 925,644 shares during the quarter. Fmr LLC owned about […]
- 03/08/2020
|
Calyxt, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- Shareholders in Calyxt, Inc. (NASDAQ:CLXT) had a terrible week, as shares crashed 31% to US$4.38 in the week since its...
- 03/07/2020
|
Calyxt (NASDAQ:CLXT) Upgraded at Zacks Investment Research
- Zacks Investment Research upgraded shares of Calyxt (NASDAQ:CLXT) from a sell rating to a hold rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well […]
- 03/07/2020
|
Goldman likes GW Pharma in premarket analyst action
- ACADIA Pharmaceuticals (NASDAQ:ACAD) initiated with Buy rating and $69 (55% upside) price target at Citigroup.Alector (NASDAQ:ALEC) initiated with Buy rating and $40 (36% upside) price target at Citi.
- 03/06/2020
|
Calyxt (CLXT) Gets a Buy Rating from National Securities Corp
- In a report released today, Ben Klieve from National Securities Corp maintained a Buy rating on Calyxt (CLXT), with a price target of $16.00. The
- 03/06/2020
|
Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q4 2019 Results - Earnings Call Transcript
- Calyxt, Inc. (NASDAQ:CLXT) Q4 2019 Earnings Conference Call March 05, 2020, 08:30 AM ET Company Participants Chris Tyson - MD, MZ North America, IR Jim Blome -
- 03/05/2020
|
Calyxt Reports Record Fourth Quarter and Full Year 2019 Financial Results
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the fourth quarter and full year ended December 31, 2019.
- 03/05/2020
|
Yves J. Ribeill Sells 9,990 Shares of Calyxt Inc (NASDAQ:CLXT) Stock
- Calyxt Inc (NASDAQ:CLXT) Director Yves J. Ribeill sold 9,990 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $5.46, for a total value of $54,545.40. Following the transaction, the director now directly owns 38,320 shares of the company’s stock, valued at […]
- 03/04/2020
|
Calyxt (CLXT) to Release Quarterly Earnings on Thursday
- Calyxt (NASDAQ:CLXT) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of ($0.39) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Shares of Calyxt stock opened […]
- 03/03/2020
|
Essex Investment Management Co. LLC Raises Stake in Calyxt Inc (NASDAQ:CLXT)
- Essex Investment Management Co. LLC raised its holdings in Calyxt Inc (NASDAQ:CLXT) by 284.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 86,315 shares of the company’s stock after purchasing an additional 63,879 shares during the quarter. Essex Investment Management Co. LLC […]
- 02/29/2020
|
Zacks Investment Research Lowers Calyxt (NASDAQ:CLXT) to Sell
- Zacks Investment Research downgraded shares of Calyxt (NASDAQ:CLXT) from a hold rating to a sell rating in a research report report published on Tuesday, Zacks.com reports. According to Zacks, “Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as […]
- 02/26/2020
|
Calyxt Inc to Post FY2024 Earnings of ($1.22) Per Share, Jefferies Financial Group Forecasts (NASDAQ:CLXT)
- Calyxt Inc (NASDAQ:CLXT) – Analysts at Jefferies Financial Group issued their FY2024 earnings per share estimates for shares of Calyxt in a research note issued to investors on Thursday, February 20th. Jefferies Financial Group analyst L. Alexander expects that the company will post earnings per share of ($1.22) for the year. Other equities research analysts […]
- 02/25/2020
|
Introducing Calyxt (NASDAQ:CLXT), The Stock That Slid 61% In The Last Year
- Calyxt, Inc. (NASDAQ:CLXT) shareholders will doubtless be very grateful to see the share price up 64% in the last...
- 02/23/2020
|
Judge takes rare step to help serve elusive Ghislaine Maxwell with lawsuit
- Jeffrey Epstein crony Ghislaine Maxwell is so impossible to find that a Manhattan judge has taken the rare step of allowing her to be served with a new lawsuit — by email, according to a federal court filing.
- 02/15/2020
|
Calyxt to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Thursday, March 5, 2020 at 8:30 a.m. Eastern Time
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 5, 2020 at 8:30 a.m. Eastern time to dis
- 02/10/2020
|
Those Who Purchased Calyxt (NASDAQ:CLXT) Shares A Year Ago Have A 52% Loss To Show For It
- It is doubtless a positive to see that the Calyxt, Inc. (NASDAQ:CLXT) share price has gained some 55% in the last...
- 02/10/2020
|
Calyxt (CLXT) Receives a Buy from National Securities Corp
- In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Calyxt (CLXT), with a price target of $16.00. The
- 02/10/2020
|
Calyxt Achieves 2020 Soybean Contracted Acreage Goal of 100,000 Acres
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has achieved its 2020 contracted acreage target, successfully contracting 100,000 soybean acres with U.S. farmers.
- 02/07/2020
|
Calyxt Appoints Bobby Williams as Gene Editing Director to Expand Innovation and Product Pipeline
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has appointed Bobby Williams, Ph.D. to the newly created role of Director of Gene Editing to further expand Calyxt’s innovation, product pipeline, and trait discovery efforts and inform product advancement decisions.
- 01/23/2020
|
Calyxt Issues Stockholder Letter
- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has released the following letter to its stockholders from Jim Blome, Chief Executive Officer.
- 01/21/2020
|
Read This Before Buying Calyxt, Inc. (NASDAQ:CLXT) Shares
- We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
- 01/19/2020
|
These Gene-Editing Pioneers Are Making Bold Bets in Agriculture
- Investors shouldn't forget that the world of biotech extends beyond biopharmaceuticals.
- 01/18/2020
|
Hedge Funds Have Never Been More Bullish On Calyxt, Inc. (CLXT)
- "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). This appears to be the longest and most severe drought for value […]
- 12/20/2019
|
Analysts Recommend These 2 Falling Knives
- They have a low financial burden, which reduces the risk of loss for investors Continue reading...
- 11/17/2019
|
When Will Calyxt, Inc. (NASDAQ:CLXT) Turn A Profit?
- Calyxt, Inc.'s (NASDAQ:CLXT): Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops...
- 11/10/2019
|
Alleged Epstein victim says she holds Victoria's Secret billionaire "responsible for what happened to me"
- A woman allegedly attacked by Jeffrey Epstein said she holds Victoria’s Secret billionaire Leslie Wexner “responsible for what happened to me” because she was staying on a property monitored by Wexner and his wife and guarded by his security team,
- 10/06/2019
|
A Base Editing IPO from Beam Therapeutics
- The ability to modify genes may be one of the most promising disruptive technologies there is today. As the general public learns about the potential of gene editing, retail investors will be looking for stocks that provide some exposure to it. In the case of gene editing, there are three stocks that would be considered pure plays on the theme - at least the last time we checked. That would have been last March when we wrote about A Few Updates on the Progress of Gene Editing noting that 'with patents being filed and issued left and right, it’s also starting to look like there is no
- 10/01/2019
|
Companies Like Calyxt (NASDAQ:CLXT) Are In A Position To Invest In Growth
- Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- 09/20/2019
|
Centric Software PLM Inks Partnerships with CLO, Browzwear and EFI
Optitex
- Building on its commitment to develop innovations that drive retail transformation for brands, retailers and manufacturers, Product Lifecycle Management (PLM) market leader Centric Software has pioneered a …
- 09/20/2019
|
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
- Agriculture Operations Outlook: Tariffs to Mar Organic Gains
- 08/19/2019
|
Tractor Supply's Robust Omni-Channel Efforts to Drive Growth
- Tractor Supply (TSCO) benefits from its omni-channel efforts that include expansion of store base and technological advancements.
- 08/15/2019
|
Calyxt, Inc. (CLXT) Q2 2019 Earnings Call Transcript
- CLXT earnings call for the period ending June 30, 2019.
- 08/08/2019
|
Sunflower prices see upward movement
- At the North Dakota crush plants sunflower prices continued their upward movement a week ago. Old crop NuSun prices ended the week up 5 to 20 cents with High Oleic
- 08/02/2019
|
Calyxt (CLXT) Expected to Beat Earnings Estimates: Should You Buy?
- Calyxt (CLXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/31/2019
|
Calyxt, Inc. (NASDAQ:CLXT) Insiders Have Been Selling
- We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
- 07/22/2019
|
Calyxt, Inc. (CLXT) Q1 2019 Earnings Call Transcript
- CLXT earnings call for the period ending March 31, 2019.
- 05/09/2019
|
Earnings Preview: Calyxt (CLXT) Q1 Earnings Expected to Decline
- Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/29/2019
|
Honoring ‘The Farmers’ of the world
- When people ask me what the best part of my job is I always say, without exception, telling the stories about the people of agriculture. It’s not necessarily talking about
- 02/18/2019
|
